Imaging Agents

BCS: MarginProbe Reduces Re-Excision Rate Post-Lumpectomy

BCS: MarginProbe Reduces Re-Excision Rate Post-Lumpectomy

A novel device that emits an electric field and detects cancerous tissue from its characteristic returning signal, known as MarginProbe, may reduce the rate of re-excision for patients undergoing lumpectomy for breast cancer, without a significant increase in the volume of tissue excised.